hepatoАнналы хирургической гепатологииAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery1995-54642408-9524НЭИКОН ИСП10.16931/1995-5464.2019437-44hepato-529Research ArticleКОМПЛЕКСНОЕ ЛЕЧЕНИЕ МЕТАСТАЗОВ КОЛОРЕКТАЛЬНОГО РАКАCOMPREHENSIVE TREATMENT OF COLORECTAL CANCER METASTASESМетастазы колоректального рака в печени, не контролируемые системной химиотерапией: роль внутриартериальной химиотерапииIntraarterial chemotherapy in treatment of unresectable colorectal liver metastases refractory to systemic chemotherapyhttps://orcid.org/0000-0002-7683-5042ПоликарповА. А.PolikarpovA. A.

доктор мед. наук, врач отделения ангиографии, профессор кафедры радиологии и хирургических технологий 197758, Санкт-Петербург, поселок Песочный, ул. Ленинградская, д. 70, Российская Федерация 

Тел.: 8-812-596-87-66Факс: 8-812-596-67-05

Doct. of Sci. (Med.), Physician of the Department of Angiography, Professor

Phone: +7-812-596-87-66. Fax: +7-812-596-67-05 70, Leningradskaya str., Pesochny, 197758, S.-Petersburg, Russian Federation

pol1110@mail.ruhttps://orcid.org/0000-0001-9190-116XТаразовП. Г.TarazovP. G.

70, Leningradskaya str., Pesochny, 197758, S.-Petersburg, Russian Federation

tarazovp@mail.ruhttps://orcid.org/0000-0003-3323-7576КагачеваТ. И.KagachevaT. I.

Врач хирург отделения ангиографии

197758, Санкт-Петербург, поселок Песочный, ул. Ленинградская, д. 70, Российская Федерация 

70, Leningradskaya str., Pesochny, 197758, S.-Petersburg, Russian Federation

tatiana.kagacheva@mail.ruhttps://orcid.org/0000-0002-8415-946XБоровикВ. В.BorovikV. V.

70, Leningradskaya str., Pesochny, 197758, S.-Petersburg, Russian Federation

borovik1968@yandex.ruhttps://orcid.org/0000-0002-6878-6762КозловА. В.KozlovA. V.

70, Leningradskaya str., Pesochny, 197758, S.-Petersburg, Russian Federation

av_kozlov@mail.ruhttps://orcid.org/0000-0002-8746-8452ГрановД. А.GranovD. A.

член-корр. РАН, доктор мед. наук, профессор, научный руководитель 

197758, Санкт-Петербург, поселок Песочный, ул. Ленинградская, д. 70, Российская Федерация

70, Leningradskaya str., Pesochny, 197758, S.-Petersburg, Russian Federation

dmitriigranov@gmail.comФГБУ “Российский научный центр радиологии и хирургических технологий им. акад. А.М. Гранова” Минздрава РоссииРоссияGranov Russian Scientific Centre of Radiology and Surgical Technologies, Ministry of Health of the Russian FederationRussian Federation2019031220192443744Copyright © Поликарпов А.А., Таразов П.Г., Кагачева Т.И., Боровик В.В., Козлов А.В., Гранов Д.А., 20192019Поликарпов А.А., Таразов П.Г., Кагачева Т.И., Боровик В.В., Козлов А.В., Гранов Д.А.Polikarpov A.A., Tarazov P.G., Kagacheva T.I., Borovik V.V., Kozlov A.V., Granov D.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://hepato.elpub.ru/jour/article/view/529печеньметастазы колоректального ракавнутриартериальная химиотерапияхимиоэмболизацияхимиорезистентностьlivercolorectal cancer metastasesintraarterial chemotherapychemoembolizationchemoresistanceReferencesАлиев В.А., Барсуков Ю.Ю., Николаев А.В. Колоректальный рак с синхронными отдаленными метастазами: обоснование циторедуктивных операций и перспектив – взгляд хирурга. Онкологическая колопроктология. 2012; 4: 15–20.Aliev V.A., Barsukov Y.Y., Nikolaev A.V. Colorectal cancer with synchronous distant metastases: rationale for cytoreductive surgery and its perspectives – a surgeon’s view. Oncological Coloproctology. 2012; 4: 15–20. (In Russian)Горчаков С.В., Правосудов И.В., Васильев С.В., Олейник В.В., Оношко М.В., Попов Д.Е. Современные подходы к лечению больных колоректальным раком с метаста зами в печень. Вестник Санкт-Петербургского университета. Медицина. 2015; 3: 55–68.Gorchakov S.V., Pravosudov I.V., Vasil'ev S.V., Oleynic V.V., Onoshko M.V., Popov D.E. Modern approaches to treatment of colorectal cancer patients with liver metastases. Vestnik of Saint Petersburg University. Medicine. 2015; 3: 55–68. (In Russian)Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Московский научно-исследовательский онкологический институт имени П.А. Герцена. М., 2017. 250 c.Kaprin A.D., Starinskij V.V., Petrova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2015 godu (zabolevaemost' i smertnost') [Malignant neoplasms in Russia in 2015 (morbidity and mortality)]. Moscow Research Cancer Institute named after P.A. Herzen. Moscow, 2017. 250 p. (In Russian)Трякин А.А., Артамонова Е.В., Болотина Л.В. Колоректальный рак. RUSSCO, 2016. С. 266–285.Tryakin A.A., Artamonova E.V., Bolotina L.V. Kolorektal'nyj rak [Practical recommendations for the treatment of malignant tumors of the Russian Society of Clinical Oncology]. RUSSCO, 2016. P. 266–285. (In Russian)Adenis A., de la Fouchardiere C., Paule B., Burtin P., Tougeron D., Wallet J., Dourthe L.M., Etienne P.L., Mineur L., Clisant S., Phelip J.M., Kramar A., Andre T. Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program. BMC Cancer. 2016; 16 (7): 412–420. https://doi.org/10.1186/s12885-016-2440-9Adenis A., de la Fouchardiere C., Paule B., Burtin P., Tougeron D., Wallet J., Dourthe L.M., Etienne P.L., Mineur L., Clisant S., Phelip J.M., Kramar A., Andre T. Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program. BMC Cancer. 2016; 16 (7): 412–420. https://doi.org/10.1186/s12885-016-2440-9Ychou M., Viret F., Kramar A., Desseigne F., Mitry E., Guimbaud R., Delpero J.R., Rivoire M., Quénet F., Portier G., Nordlinger B. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. Cancer Chemother. Pharmacol. 2008; 62 (2): 195–201.Ychou M., Viret F., Kramar A., Desseigne F., Mitry E., Guimbaud R., Delpero J.R., Rivoire M., Quénet F., Portier G., Nordlinger B. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. Cancer Chemother. Pharmacol. 2008; 62 (2): 195–201.Гранов А.М., Давыдов М.И. Интервенционная радиология в онкологии (пути развития и технологии). Под ред. Таразова П.Г., Гранова Д.А. 2-е изд., доп. СПб., 2013. 546 с.Granov A.M., Davydov M.I. Intervencionnaya radiologiya v onkologii (puti razvitiya i tekhnologii) [Interventional radiology in oncology (ways of development and technology)]. Tarazov P.G., Granov D.A., eds. 2nd ed., add. Saint Petersburg, 2013. 546 p. (In Russian)Bhutiani N., Martin R.C. Transarterial therapy for colorectal liver metastases. Surg. Clin. North. Am. 2016; 96 (2): 369–391. https://doi.org/10.1016/j.suc.2015.12.003Bhutiani N., Martin R.C. Transarterial therapy for colorectal liver metastases. Surg. Clin. North. Am. 2016; 96 (2): 369–391. https://doi.org/10.1016/j.suc.2015.12.003Bhutiani N., Akinwande O., Martin R. Efficacy and toxicity of hepatic intra-arterial drug-eluting (Irinotecan) bead (DEBIRI) therapy in Irinotecan-refractory unresectable colorectal liver metastases. World J. Surg. 2016; 40 (5): 1178–1190. https://doi.org/10.1007/s00268-015-3386-9Bhutiani N., Akinwande O., Martin R. Efficacy and toxicity of hepatic intra-arterial drug-eluting (Irinotecan) bead (DEBIRI) therapy in Irinotecan-refractory unresectable colorectal liver metastases. World J. Surg. 2016; 40 (5): 1178–1190. https://doi.org/10.1007/s00268-015-3386-9Scevola G., Loreni G., Rastelli M., Sposato S., Ramponi S., Miele V. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization. Med. Oncol. 2017; 34 (3): 37–41. https://doi.org/10.1007/s12032-017-0890-9Scevola G., Loreni G., Rastelli M., Sposato S., Ramponi S., Miele V. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization. Med. Oncol. 2017; 34 (3): 37–41. https://doi.org/10.1007/s12032-017-0890-9Vogl T.J., Lahrsow M., Albrecht M.H., Hammerstingla R., Thompsonb Z.M., Gruber-Rouh T. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation. Eur. J. Radiol. 2018; 102 (5): 138–145. https://doi.org/10.1016/j.ejrad.2018.03.015Vogl T.J., Lahrsow M., Albrecht M.H., Hammerstingla R., Thompsonb Z.M., Gruber-Rouh T. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation. Eur. J. Radiol. 2018; 102 (5): 138–145. https://doi.org/10.1016/j.ejrad.2018.03.015Gennari L., Doci R., Bozzetti F., Veronesi U. Proposal for a clinical classification of liver metastases. Tumori. 1982; 68 (5): 443–449.Gennari L., Doci R., Bozzetti F., Veronesi U. Proposal for a clinical classification of liver metastases. Tumori. 1982; 68 (5): 443–449.Konopke R., Roth J., Volk A., Pistorius S., Folprecht G., Zoephel K., Schuetze C., Laniado M., Saeger H., Kersting S. Colorectal liver metastases: an update on palliative treatment options. J. Gastrointest. Liver Dis. 2012; 21 (1): 83–91.Konopke R., Roth J., Volk A., Pistorius S., Folprecht G., Zoephel K., Schuetze C., Laniado M., Saeger H., Kersting S. Colorectal liver metastases: an update on palliative treatment options. J. Gastrointest. Liver Dis. 2012; 21 (1): 83–91.Schiergens T.S., von Einem J., Thomas M.N. Multidisciplinary treatment of colorectal liver metastases. Minerva Med. 2017; 108 (6): 527–546. https://doi.org/10.23736/S0026-4806.17.05371-XSchiergens T.S., von Einem J., Thomas M.N. Multidisciplinary treatment of colorectal liver metastases. Minerva Med. 2017; 108 (6): 527–546. https://doi.org/10.23736/S0026-4806.17.05371-XFiorentini G., Aliberti C., Sarti D., Coschiera P., Tilli M., Mulazzani L., Giordani P., Graziano F., Gonzalez A.M., Marcos R.G., Mugnoz F.G., Cantore M., Ricci S., Catalano V., Mambrini A. Locoregional therapy and systemic cetuximab to treat colorectal liver metastases. World J. Gastrointest. Oncol. 2015; 15 (6): 47–54. https://doi.org/10.4251/wjgo.v7.i6.47Fiorentini G., Aliberti C., Sarti D., Coschiera P., Tilli M., Mulazzani L., Giordani P., Graziano F., Gonzalez A.M., Marcos R.G., Mugnoz F.G., Cantore M., Ricci S., Catalano V., Mambrini A. Locoregional therapy and systemic cetuximab to treat colorectal liver metastases. World J. Gastrointest. Oncol. 2015; 15 (6): 47–54. https://doi.org/10.4251/wjgo.v7.i6.47van Hazel G., Pavlakis N., Goldstein D., Olver I.N., Tapner M.J., Price D., Bower G.D., Briggs G.M., Rossleigh M.A., Taylor D.J., George J. et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J. Clin. Oncol. 2009; 7 (25): 4089–4095. https://doi.org/10.1200/JCO.2008.20.8116van Hazel G., Pavlakis N., Goldstein D., Olver I.N., Tapner M.J., Price D., Bower G.D., Briggs G.M., Rossleigh M.A., Taylor D.J., George J. et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J. Clin. Oncol. 2009; 7 (25): 4089–4095. https://doi.org/10.1200/JCO.2008.20.8116Cercek A., Boucher T., Gluskin J., Aguiló A., Chou J.F., Connell L.C., Capanu M., Reidy-Lagunes D., D'Angelica M., Kemeny N.E. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. J. Surg. Oncol. 2016; 114 (6): 655–663. https://doi.org/10.1002/jso.24399Cercek A., Boucher T., Gluskin J., Aguiló A., Chou J.F., Connell L.C., Capanu M., Reidy-Lagunes D., D'Angelica M., Kemeny N.E. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. J. Surg. Oncol. 2016; 114 (6): 655–663. https://doi.org/10.1002/jso.24399Arai Y., Aoyama T., Inaba Y., Okabe H., Ihaya T., Kichikawa K., Ohashi Y., Sakamoto J., Oba K., Saji S. Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study). Asia Pac. J. Clin. Oncol. 2015; 11 (1): 41–48. https://doi.org/10.1111/ajco.12324Arai Y., Aoyama T., Inaba Y., Okabe H., Ihaya T., Kichikawa K., Ohashi Y., Sakamoto J., Oba K., Saji S. Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study). Asia Pac. J. Clin. Oncol. 2015; 11 (1): 41–48. https://doi.org/10.1111/ajco.12324Massmann A., Rodt T., Marquardt S., Seidel R., Thomas K., Wacker F., Richter G.M., Kauczor H.U., Bücker A., Pereira P.L., Sommer C.M. Transarterial chemoembolization (TACE) for colorectal liver metastases – current status and critical review. Langenbeck’s Arch. Surg. 2015; 400 (6): 641–659. https://doi.org/10.1007/s00423-015-1308-9Massmann A., Rodt T., Marquardt S., Seidel R., Thomas K., Wacker F., Richter G.M., Kauczor H.U., Bücker A., Pereira P.L., Sommer C.M. Transarterial chemoembolization (TACE) for colorectal liver metastases – current status and critical review. Langenbeck’s Arch. Surg. 2015; 400 (6): 641–659. https://doi.org/10.1007/s00423-015-1308-9Gruber-Rouh T., Naguib N., Eichler K., Naguib N.N., Beeres M., Langenbach M., Vogl T.J. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int. J. Cancer. 2014; 134 (5): 1225–1231. https://doi.org/10.1159/000488644Gruber-Rouh T., Naguib N., Eichler K., Naguib N.N., Beeres M., Langenbach M., Vogl T.J. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int. J. Cancer. 2014; 134 (5): 1225–1231. https://doi.org/10.1159/000488644Goi T., Naruse T., Kimura Y., Morikawa M., Koneri K., Yamaguchi A. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer. World J. Surg. Oncol. 2015; 13 (9): 296. https://doi.org/10.1186/s12957-015-0704-5Goi T., Naruse T., Kimura Y., Morikawa M., Koneri K., Yamaguchi A. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer. World J. Surg. Oncol. 2015; 13 (9): 296. https://doi.org/10.1186/s12957-015-0704-5Zervoudakis A., Boucher T., Kemeny N. Treatment options in colorectal liver metastases: hepatic arterial infusion. Visc. Med. 2017; 33 (1): 47–53. https://doi.org/10.1159/000454693Zervoudakis A., Boucher T., Kemeny N. Treatment options in colorectal liver metastases: hepatic arterial infusion. Visc. Med. 2017; 33 (1): 47–53. https://doi.org/10.1159/000454693

The authors declare that there are no conflicts of interest present.